Reversible hair depigmentation in a patient treated with imatinib

Leuk Res. 2011 Jun;35(6):e64-6. doi: 10.1016/j.leukres.2010.11.028. Epub 2010 Dec 19.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Benzamides
  • Hair Color / drug effects
  • Hair Diseases / chemically induced*
  • Humans
  • Hypopigmentation / chemically induced*
  • Imatinib Mesylate
  • Leukemia, Myeloid, Chronic-Phase / drug therapy
  • Middle Aged
  • Piperazines / adverse effects*
  • Pyrimidines / adverse effects*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate